ProWave
PediWave
What is Shock wave therapy?
Extracorporeal Shockwave Therapy (ESWT) is a non-invasive treatment that delivers shock waves through the skin to target injured areas of the body. This therapy has been reviewed by the National Institute for Health and Care Excellence (NICE) in the UK and is FDA-approved in the United States for its safety and effectiveness.
How does the treatment work?
We utilize the Swiss DolorClast device, which generates shock waves through a high-speed projectile inside a hand-held applicator. When applied to the skin with a coupling medium, such as ultrasound gel, the impulses create a radial shock wave that spreads through the tissue, promoting healing and pain relief.
When radial shock waves from the Swiss DolorClast pass through the skin, they trigger an inflammation-like response in the injured tissue. This stimulates the body's natural healing mechanisms by increasing blood circulation, promoting the formation of new blood vessels, and enhancing metabolism in the affected area. As a result, cell regeneration is accelerated, leading to faster recovery and pain relief.
What are the benefits?
This non-invasive treatment uses pulsed sound waves, or shock waves, delivered through a specialized device applied to multiple areas of the penis. The number of shockwave pulses, along with their frequency and energy levels, is customized to each patient and specific condition, ensuring a personalized and effective approach to treatment.
Extensive clinical experience has demonstrated that shock wave therapy is a highly safe treatment with no known complications. It does not cause damage to surrounding nerves or blood vessels. In fact, this therapy is also used to treat certain cases of neuralgia, providing pain relief by stimulating nerve regeneration and improving circulation.
This treatment does not require anesthesia and is generally well tolerated, with most men experiencing only a mild tingling sensation during the procedure. The shock wave intensity can be adjusted to ensure the treatment remains comfortable and stays below the patient’s pain threshold.
What conditions can be treated?
No need for anesthetic
Non-invasive procedure
No need for surgery or medication
Treatment sessions last for an average of only 15 minutes
No hospital admission
Transient analgesic effect after treatment
No lengthy rehabilitation, loss of mobility or time away from work
Fewer complications
Strong clinical results
What conditions can be treated?
In the foot / ankle, NICE have recognised the use of shockwave therapy for:
Plantar heel pain
Plantar fasciitis
Posterior heel pain
Insertional Achilles tendonopathy / posterior heel spur
Achilles tendonopathy
Additionally, shock wave therapy has been successfully used to treat shin pain, including shin splints (medial tibial stress syndrome). Emerging research also suggests its potential effectiveness in promoting healing for stress fractures, offering a promising non-invasive treatment option.
How successful is the treatment?
Clinical trials conducted by leading medical professionals worldwide have shown that the Swiss DolorClast device is effective in treating conditions recognized by the National Institute for Health and Care Excellence (NICE). These trials highlight the device’s ability to provide safe and successful outcomes for various musculoskeletal conditions.
We have seen excellent results with this treatment and contribute our patient outcomes to a national database to help provide more evidence on its effectiveness. However, like any treatment, it is not a one-size-fits-all solution for every patient. Based on our experience, shock wave therapy tends to be most effective for patients who have already tried common or standard treatments for their condition and use this therapy to help accelerate and jumpstart the healing process.
How do I book treatment?
A consultation is required to confirm the diagnosis, assess your suitability for the treatment, and determine if any additional investigations are necessary. Typically, a course of treatment involves one session per week for three weeks. The effects of the therapy tend to increase over time, with the full outcome being assessed 12 weeks after the final treatment session.
